![]() |
|
Programm & Abstracts "Innovationen in der Augenheilkunde" | |
![]() Aktuelle Tagungsinformationen News and Updates Anmeldung zur Tagung Registration Hotelbuchung Hotel Registration Grußwort Welcome address Beteiligte Gesellschaften Societies involved Eröffnung des Kongresses Opening Ceremony Preise Awards Wissenschaftliches Programm Scientific program Posterpräsentationen Poster Presentation Kurse Courses Begleitende Veranstaltungen Collateral Events Rahmenprogramm Social program Jubiläumsparty Jubilee Party DOG Information DOG Information Allgemeine Informationen General Information Autorenindex Index of Authors Ausstellerliste Exhibitors Sponsoren Sponsors Teilnahmegebühren Registration fees Impressum DOG Homepage |
Anecortave Acetate: A New Angiostatic Agent in Clinical Studies for Treatment of Exudative Age-related Macular Degeneration (AMD) Müller-Velten R., Michels S., Beckendorf A., Schmidt-Erfurth U.,
Introduction: The angiostatic agent anecortave acetate (AA) has been shown to inhibit blood vessel growth in multiple preclinical studies. Currently two clinical, masked, randomized trials for subfoveal choroidal neovascularisation (CNV) secondary to age-related maculardegeneration (AMD) in North America and the EU have been completed. |
|